Antioxidant supplementation for sickle cell disease.
- 2024-05-22
- Meta-Analysis · n = 1,609
- The Cochrane database of systematic reviews 2024(5)
- Abiola B Bolarinwa
- Olabisi Oduwole
- Joseph Okebe
- Ann A Ogbenna
- Oluwakemi E Otokiti
- Adejoke T Olatinwo
- PubMed: 38775255
- DOI: 10.1002/14651858.cd013590.pub2
- High evidence
- Clinical
Zinc may be better than placebo at increasing haemoglobin level (g/dL) (MD 1.26, 95% CI 0.44 to 1.26; 1 study, 36 participants; low-certainty evidence).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes